Drug
Alfimeprase clinical trials
How studies write it
Studies that test it under each name
Name
Studies by the year they started
6 studies that test it; most in 2005 (2)
| Year | Studies |
|---|---|
| 2003 | 1 |
| 2005 | 2 |
| 2006 | 2 |
| 2007 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 7 · Other 0
ARCA Biopharma, Inc. (7)
Studies
Open first, then newest update. How each study uses alfimeprase is read from its arms, and is right about nine times in ten.
Testing it · 7
- Trial of a Novel Fibrinolytic (Alfimeprase) to Clear Thrombosed Vascular Access DevicesCompletedPhase 2ARCA Biopharma, Inc.NCT00073515Written as Alfimeprase
- Alfimeprase for Thrombolysis in Acute Peripheral Arterial OcclusionCompletedPhase 2ARCA Biopharma, Inc.NCT00073554Written as Alfimeprase
- Safety and Efficacy Study of Alfimeprase in Subjects With Occluded CathetersCompletedPhase 3ARCA Biopharma, Inc.NCT00322270Written as Alfimeprase
- Safety and Efficacy Study of Alfimeprase in Subjects With Occluded Central CathetersCompletedPhase 3ARCA Biopharma, Inc.NCT00346424Written as Alfimeprase
- Phase 2 Proof-of-Concept Study of the Safety and Efficacy of Alfimeprase to Rapidly Open Arteries and Restore Brain Function Following a StrokeTerminatedPhase 2ARCA Biopharma, Inc.NCT00499902Written as alfimeprase
- Study of Alfimeprase to Rapidly Dissolve Blood Clots in the Leg and Help Prevent the Need for Surgery on Leg ArteriesCompletedPhase 3ARCA Biopharma, Inc.NCT00115999Written as alfimeprase
- Study of Alfimeprase's Ability to Dissolve Blood Clots in the Leg and Help Prevent the Need for SurgeryTerminatedPhase 3ARCA Biopharma, Inc.NCT00338585Written as alfimeprase
Codes
What other systems call alfimeprase · ClinicalTrials.gg INT004381
- MeSH (NLM) C436755alfimepraseOne source ClinicalTrials.gov
- UNII (FDA) GPN9HBH1HSALFIMEPRASEOne source FDA
- NCI Thesaurus C79877AlfimepraseOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C436755 | alfimeprase | One source ClinicalTrials.gov |
| UNII (FDA) | GPN9HBH1HS | ALFIMEPRASE | One source FDA |
| NCI Thesaurus | C79877 | Alfimeprase | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.